Presence of the GFI1-36N single nucleotide polymorphism enhances the response of MLL-AF9 leukemic cells to CDK4/6 inhibition

Vorwerk J, Sun K, Frank D, Neumann F, Hüve J, Budde PM, Ahmed HMM, Opalka B, Lenz G, Jayavelu AK, Khandanpour C

Research article (journal) | Peer reviewed

Details about the publication

JournalFrontiers in Oncology
Volume2022
Page range3801null
StatusPublished
Release year2022 (08/08/2022)
DOI10.3389/fonc.2022.903691
Keywordsacute myeloid leukemia; Gfi1; single nucleotide polymorphism; Cdks; Cdk inhibition; palbociclib

Authors from the University of Münster

Hüve, Jana
Institute of Medical Physics and Biophysics